Original language | English (US) |
---|---|
Pages (from-to) | 1971-1972 |
Number of pages | 2 |
Journal | Annals of Oncology |
Volume | 27 |
Issue number | 10 |
DOIs | |
State | Published - Oct 2016 |
Funding
The trial was supported by the Swiss Government through the State Secretariat for Education, Research and Innovation, SERI. Sanofi (Switzerland) provided financial contribution and docetaxel free of charge. No funding for this Letter. MP Advisory for Sanofi, SP Honoraria from and Advisory role for: Amgen, Lilly, Pfizer, Roche, Astra Zeneca, Boehringer Ingelheim, MSD, Merk Serono, Celgene, Debiopharm, Novartis and BMS. Other authors: no conflicts. The trial was supported by the Swiss Government through the State Secretariat for Education, Research and Innovation, SERI. Sanofi (Switzerland) provided financial contribution and docetaxel free of charge.
ASJC Scopus subject areas
- Hematology
- Oncology